A team of researchers at McMaster University is working on an inhaled COVID-19 vaccine that offers better protection and is less costly to produce, store and ship.
The WHO's move to rethink the names of viral infections is entirely appropriate, the infectious disease expert notes.
Our inhaled COVID-19 vaccine would go directly to where the body needs it: the surface of the airways. This means less waste and more benefit, lower costs and reduced side-effects.
McMaster logo
McMaster logo
